Intellectual Property

Maximize control of your IP portfolio

Maintain accurate IP data with flexible, intuitive software. And collaborate with ease, giving you more time to make strategic decisions. That’s the power of Thomson IP Manager.

Make the most informed decisions about your IP assets and increase efficiency by leveraging the most flexible software and collaboration tools to maximize the value of your IP portfolio and align your IP strategy with your business. See which edition fits your organization.

The World in 2025: 10 predictions of innovation

1007248_2025

Welcome to Thomson Reuters Exchange! We created Exchange, as the name suggests, as a forum for dialogue, a digital publication where ideas and insights, information, news and analysis can be exchanged and shared across the global ecosystem of professionals in a dynamic, interactive format. We invite you to experience the rich content and interactive features on your iPad or Android tablet by downloading it from the App StoreGoogle Play or on Amazon. Or, to learn more about Exchange and stay abreast of the latest features, functionality and content in this issue and subsequent issues, visit our website.

“It is said that the present is pregnant with the future.” – Voltaire (1694-1778)

As far back as one can look in history, humans have tried to predict everything from the weather and rise and fall of tides to, in more recent times, stock performance and who will reign as champion in a sporting event. From Nostradamus to Toffler to Kurzweil, academics, astronomers, economists, futurists, mathematicians, scientists, sociologists, sports enthusiasts and others have contributed to the science – and art – of predicting what is to come.

It was only fitting then, that our IP & Science business, with innovation at its core, should also partake in leveraging its assets to forecast the future. With its rich scientific and intellectual property repositories, and deep industry expertise, this business is dedicated to helping customers research, innovate and commercialize tomorrow’s inventions.

The group compiled a paper outlining 10 innovation predictions for the world in 2025, based on research done by Thomson Reuters analysts using the company’s patent and scientific literature solutions.

In some cases, the analysts found a growing body of work that gave additional credence to the prediction. In others, the topic was still emerging. In all instances, they followed a trail of current research and innovation activity to connect the dots and make these innovation predictions. (more…)

Nobel laureates – Graphic of the day

Today’s graphic shows the total number of Nobel Prize laureates awarded from 1901 to 2013 by country of origin. See at a glance how the work of this year’s Citation Laureates has already transformed our everyday lives, or is expected to in the near future.

nobel laureates

Would you like infographics like this on your website, blog or other social media? Contact us and visit our Reuters Agency blog for insights and discussions on the changing media industry.

Thomson Reuters 2014 Citation Laureates – Graphic of the day

Our Intellectual Property & Science business recently announced its 2014 “Nobel-class” Citation Laureates. Having accurately forecast 35 Nobel Prize winners since its inception in 2002, the annual Thomson Reuters Citation Laureates study mines scientific research citations to identify the most influential researchers in the fields of chemistry, physics, medicine and economics. Today’s graphic shows our top picks for 2014 and the technologies they’ve influenced.

Thomson Reuters 2014 Citation Laureates

Make sure to check out the complete list of the 2014 Nobel predictions and follow @TR_ScienceWatch on Twitter.

Nobel Prize predictions

RTR30MNU_72dpi

The 2014 Citation Laureates are our picks for the top Nobel Prize contenders in the fields of chemistry, physics, medicine and economics. The list includes 26 researchers who represent 25 academic and research organizations, and eight countries.

Every year, we share predictions just ahead of the announcements of the Nobel Prize winners. On Oct. 6, the Nobel Committees will begin announcing the winners to honor the world’s most influential researchers for achievements in physics, chemistry, physiology or medicine, literature, economics, and for peace.

Long tradition of identifying excellence in research

Thomson Reuters has accurately forecast 35 Nobel Prize winners since first publishing the study in 2002.

(more…)

‘Challenging your beliefs about “information and belief,”‘ by Frederick A. Brodie

 

 

For a one-minute audio intro to the commentary, click here.

 

WestlawNext users: Click here to read the full article on WestlawNext.

Frederick A. Brodie

The World in 2025 – Teleportation is tested

It’s human nature to want to know what’s coming. It seems fitting, then, that our IP & Science business, with innovation at its core, should also partake in leveraging its assets to forecast the future. The following is one prediction from our new report that features 10 innovation predictions for the world in 2025. Make sure to check out the entire series of posts and download the full report here.

Kinematical techniques used to understand the Higgs Boson particles generated in the Large Hadron Collider advance such that quantum teleportation is more commonplace.

World-2025_pdf__page_24_of_28_The frequent request heard on Star Trek® will not be such an abstract concept as we move through the 21st Century.

Since the 2013 success at the CERN’s Large Hadron Collider (LHC), research related to the Higgs Boson particle has increased. In fact, papers on this topic have been the most prevalent in fundamental physics in 2014.

Measurement techniques developed to understand the particles generated in the LHC were ground breaking through the use of new kinematical techniques. Kinematics is a form of classic mechanics that studies the motion of points, objects and groups of objects regardless of the impetus for motion.

We are on the precipice of this field’s explosion; it is truly an emerging research front. Early indicators point to a rapid acceleration of research leading to the testing of quantum teleportation in 2025.

Although in 2025 we as humans won’t yet be able to teleport through space, a significant investment in and testing of quantum teleportation will be underway using other forms of matter.

Download the full report: The World in 2025: 10 Predictions of Innovation

The World in 2025 – DNA mapping at birth is the norm to manage disease risk

It’s human nature to want to know what’s coming. It seems fitting, then, that our IP & Science business, with innovation at its core, should also partake in leveraging its assets to forecast the future. The following is one prediction from our new report that features 10 innovation predictions for the world in 2025. Make sure to check out the entire series of posts and download the full report here.

The evolution of micro-total analysis systems (single- cell analysis) and advancements in nanotechnology, coupled with more widespread Big Data technologies, make DNA-mapping at birth will become the norm, as well as part of one’s annual physician exam.

World-2025_pdf__page_22_of_28_As the volume of matter which can be manipulated in the lab gets smaller and smaller, greater possibilities for precise medical screening emerge. Blood tests potentially become a thing of the past, as nano-probes will be inserted into a patient to gather data over longer periods of time and provide greater accuracy.

Micro-total analysis systems will be much closer to providing the sensitivity and selectivity required to make in vivo measurements for diagnosis. Single-cell analysis, currently in the research phase, will be mainstream and set to replace traditional flow cytometry for the isolation, purification and separation of cells in immunology testing.

Big Data will be embedded in society in the next decade, allowing medical researchers and physicians to use it to their advantage. In 2025, humans will have their DNA mapped at birth and checked annually to identify any changes that could point to the onset of autoimmune diseases.

Download the full report: The World in 2025: 10 Predictions of Innovation

Q&A on software patents and the recent Alice decision

In their recent Westlaw Journal commentary, Software Patents Survive Supreme Court’s Alice Decision, but Questions Linger, Bracewell & Giuliani partners David J. Ball and Douglas F. Stewart discuss the U.S. Supreme Court’s recent decision regarding software patents and “abstract ideas.”

While they say the decision gives less guidance than most practitioners hoped, it nevertheless provides instruction on analyzing patentability.

We sit down and talk with them a bit more about software patents and why they cause so much trouble.

(more…)

The World in 2025 – Cancer treatments have very few toxic side effects

It’s human nature to want to know what’s coming. It seems fitting, then, that our IP & Science business, with innovation at its core, should also partake in leveraging its assets to forecast the future. The following is one prediction from our new report that features 10 innovation predictions for the world in 2025. Make sure to check out the entire series of posts and download the full report here.

Drug development is so much more precise, binding to specific proteins and using antibodies to give exact mechanisms of action, that the debilitating effects of toxic chemicals on patients is significantly reduced.

Just as Big Data is enabling companies to deliver personalized customer experiences, so too is life sciences moving from broad-brush drugs to very accurate and targeted treatments that result in significantly improved patient experiences.

drug developmentThis personalized medicine movement is not new. For several years the pharmaceutical community has been working on therapies that target specific molecules and perform targeted functions. Many drugs are now developed from biotechnology and are aimed at treating specific forms of a disease.

What will be new is the availability of drugs that reduce the complications associated with certain treatments. Drugs in development are becoming so targeted that they can bind to specific proteins and use antibodies to give precise mechanisms of action.

Knowledge of specific gene mutations will be so much more advanced that scientists and physicians can treat those specific mutations. Examples of this include HER2 (breast cancer), BRAF V600 (melanoma), and ROS1 (lung cancer), among many others.

In addition, advancements in antibody production and targeting will significantly improve certain cancer treatments, such as related to the safety and activity of anti- PD-L1 antibodies in patients with advanced cancer.

The impact of these advancements will be that patients in 2025 will have much more targeted drug treatments that result in fewer toxic side effects.

Download the full report: The World in 2025: 10 Predictions of Innovation